4 April 2019
Anxiety and stress regulation will be the focus of Phase-3 investigations in high-risk clinical cohort of Synapsy’s WP#4 (Developmental Stress). Synapsy clinical researchers Dr. Camille Piguet and Dr. Paul Klauser, together with Dr. Daniel Schechter have launched a collaborative study Read more…